Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2012
06/14/2012WO2012078270A2 Efficient and effective supplement screening for the development of chemically defined media in cell culture
06/14/2012WO2012078153A1 Agents and methods for inhibiting human pluripotent stem cell growth
06/14/2012WO2012078138A1 Cell array quality control device for pathological analysis
06/14/2012WO2012078066A2 Process for the deposition of biomaterials on water repellent substrates and resulting biomaterials
06/14/2012WO2012077980A2 Stem cell culturing apparatus
06/14/2012WO2012077891A1 Patch for regenerating damaged tissue and configured with a fibrous porous 3d support
06/14/2012WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same
06/14/2012WO2012077679A1 Culture medium additive and use thereof
06/14/2012WO2012077649A1 Human monoclonal antibody
06/14/2012WO2012077614A1 Random transesterification method for fats and oils, and lipase for random transesterification
06/14/2012WO2012077421A1 Polynucleotide encoding jatropha-derived ppat and use of same
06/14/2012WO2012077175A1 Method for culturing cells
06/14/2012WO2012077128A1 A novel cell line development process to produce recombinant proteins using twin vector expression system
06/14/2012WO2012076741A1 Mesenchymal stem cells isolated from peripheral blood
06/14/2012WO2012076441A1 Feed mixing device and its use
06/14/2012WO2012075912A1 Sub-totipotent stem cell product and apparent hereditary modifying label thereof
06/14/2012WO2012056110A3 Cell culture material based on microbial cellulose
06/14/2012WO2012050829A3 Uses of il-12 and the il-12 receptor positive cell in tissue repair and regeneration
06/14/2012WO2012047951A3 Human lung stem cells and uses thereof
06/14/2012WO2012044992A3 Methods and reagents for detection and treatment of esophageal metaplasia
06/14/2012WO2012044933A3 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy
06/14/2012WO2012033763A3 Tissue-specific differentiation matrices and uses thereof
06/14/2012WO2012031233A3 Blood vessel grafts for repair, reconstruction and filler materials
06/14/2012WO2012030854A3 Compositions and methods for modulating emt and uses thereof
06/14/2012WO2012012694A3 Methods of detecting autoimmune or immune-related diseases or conditions
06/14/2012WO2011163531A3 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
06/14/2012US20120151636 Peptides for Stimulating Plant Disease Resistance
06/14/2012US20120151633 Polypeptides having endoglucanase activity and polynucleotides encoding same
06/14/2012US20120151627 Selectable marker gene and methods of use thereof in transplastomic plants
06/14/2012US20120151626 Method for excision of plant embryos for transformation
06/14/2012US20120151625 Methods for increasing genetic gain in a breeding population
06/14/2012US20120151624 Garden bean cultivar h28121
06/14/2012US20120151622 Phytophthora resistance in sweet peppers
06/14/2012US20120151620 Chloroplast transit peptides for efficient targeting of dmo and uses thereof
06/14/2012US20120151618 Pepper hybrid ps09956434
06/14/2012US20120151617 Pepper hybrid ps09967422
06/14/2012US20120151616 Pepper hybrid ps09954859
06/14/2012US20120151615 Pepper hybrid ps09943431
06/14/2012US20120151613 Mutants of activation-induced cytidine deaminase (aid) and methods of use
06/14/2012US20120151611 method of producing an antibody using a cancer cell
06/14/2012US20120149892 Nucleic Acid Molecules Encoding Antibodies That Bind Cell-Associated CA 125/O772P
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149880 Nucleic Acid Cassette For Producing Recombinant Antibodies
06/14/2012US20120149874 Method for preparing recombinant glycoproteins with high sialic acid content
06/14/2012US20120149781 Stem cell differentiation using novel light-responsive hydrogels
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149759 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
06/14/2012US20120149757 Compositions and methods for modulation of smn2 splicing
06/14/2012US20120149756 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
06/14/2012US20120149754 Methods for modulating the expression and aggregation of cag-expanded gene product in cells and methods for identifying agents useful for doing the same
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149722 Heteroaryl compounds and uses thereof
06/14/2012US20120149687 Heterocyclic compounds and uses thereof
06/14/2012US20120149673 Inhibitors of store operated calcium release
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149634 Compounds and methods for treating bone disorders and controlling weight
06/14/2012US20120149633 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom
06/14/2012US20120149598 Feeder cells for target cell induction
06/14/2012US20120149115 Targeted genomic rearrangements using site-specific nucleases
06/14/2012US20120149114 Methods For Cell Culture Using A Synthetic, Defined Collagen Mimetic Surface
06/14/2012US20120149113 Method for making nerve graft
06/14/2012US20120149112 Method for making nerve graft
06/14/2012US20120149111 Porous Polymer Scaffolds for Neural Tissue Engineering and Methods of Producing the Same
06/14/2012US20120149110 Process for production of bioartificial organ
06/14/2012US20120149109 Modulation of transthyretin expression
06/14/2012US20120149108 Cell preservation method
06/14/2012US20120149107 Process for the culturing of cells
06/14/2012US20120149106 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/14/2012US20120149105 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/14/2012US20120149104 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/14/2012US20120149103 Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149101 Methods and kits for regulating intracellular trafficking of a target protein
06/14/2012US20120149100 Cardiomyocyte cell populations
06/14/2012US20120149099 Differentiation process of mesenchymal stem cells and therapeutic use thereof
06/14/2012US20120149098 Extraction of process for mesenchymal stromal stem cells
06/14/2012US20120149087 Glucoamylase variants with altered properties
06/14/2012US20120149078 Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same
06/14/2012US20120149073 Ketoreductase Polypeptides for the Preparation of Phenylephrine
06/14/2012US20120149067 Methods for producing hyaluronan in a recombinant host cell
06/14/2012US20120149063 Process for the culturing of cells
06/14/2012US20120149060 Nucleic Acids for Cloning and Expressing Multiprotein Complexes
06/14/2012US20120149053 Carrier peptide fragment and use thereof
06/14/2012US20120149051 Devices for the production of cell clusters of defined cell numbers and cluster sizes
06/14/2012US20120149036 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit
06/14/2012US20120149031 Anti-cmet antibody and its use for the detection and the diagnosis of cancer
06/14/2012US20120149028 Detection and visualization of the cell cycle in living cells
06/14/2012US20120149025 Screening Methods for Human Embryonic Stem Cells
06/14/2012US20120149014 Methods for obtaining fetal genetic material
06/14/2012US20120149010 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148639 Substrate for feeding cells and/or tissues, cell/tissue-feeder and method for the production of the same, method for the regeneration of tissues, and method for the production of porous bodies
06/14/2012US20120148632 Methods for complex tissue engineering
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148624 Mutants of cholesterol-dependent cytolysins and uses thereof
06/14/2012US20120148607 Anti c-met antibodies
06/14/2012US20120148606 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148604 Trp inhibitors and uses thereof
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use